STOCK TITAN

Alpex Acquisition posts $924K in Q3 2026 net income

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

Alpex Acquisition Corp (ALPX), a special purpose acquisition company, reported third-quarter net income of $924,086, although it had not generated operating revenue or completed a business combination as of September 30, 2026. Trust investments generated $1,038,267 of the quarter’s income, compared with $118,072 in operating expenses; net income therefore reflected trust earnings rather than operating revenue.

At September 30, ALPX held $282,656 in cash outside its restricted Trust Account, which held $116,070,637. Current liabilities were $226,653, and $805,000 of deferred underwriting fees is payable from the Trust Account upon a business combination. Management said substantial doubt exists about its ability to continue as a going concern for one year after issuance; its plans do not alleviate that doubt. The company must complete a business combination by June 26, 2027, unless extended under its governing documents.

In November 2026, ALPX entered a non-binding letter of intent with a prospective target; the proposal remains subject to due diligence, negotiations, definitive agreements and applicable approvals. The company’s disclosure controls and procedures were not effective as of September 30, 2026.

0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 1 point

How the balance works

Positive

  • None.

Negative

  • Major pointManagement disclosed substantial doubt about going concern for one year after issuance.

Filing Explained

The advisory agreement sets fees of eight hundred thousand dollars; seventy-five thousand dollars was paid by September thirtieth, with remaining advisory payments tied to milestones.

At September 30, 2026, ALPX had not completed a business combination; it reported 11,500,000 public and 187,500 private rights, and the same respective counts of warrants, outstanding, which can lead to additional Class A shares under their terms.

Each right entitles its holder to one-fourth of a Class A share upon a qualifying combination; each whole warrant entitles its holder to one Class A share at $11.50, exercisable only after the later of 30 days after a combination or 12 months after the IPO registration becomes effective. The filing records no right conversion or warrant exercise for the quarter; if additional shares issue through these mechanisms, the share count increases and existing holders’ percentage ownership falls.

The de-SPAC advisory engagement provides for aggregate fees of $800,000, of which $75,000 had been paid by September 30; remaining payments are tied to milestones including definitive agreements, registration filings, SEC verbal clearance and completion.

If no combination closes by June 26, 2027, unless the period is extended, ALPX says it will wind up and redeem public shares from the Trust Account, net of taxes and permitted dissolution expenses. The Sponsor, officers and directors waive Trust Account liquidating distributions on Founder Shares and Private Placement Shares, but retain redemption rights for any Public Shares they hold.

Net income $924,086 Three months ended September 30, 2026
Trust investment income $1,038,267 Three months ended September 30, 2026
Operating expenses $118,072 Three months ended September 30, 2026
Cash outside Trust Account $282,656 As of September 30, 2026
Trust Account assets $116,070,637 As of September 30, 2026
Current liabilities $226,653 As of September 30, 2026
Deferred underwriting commission $805,000 Payable from the Trust Account upon completion of a business combination
Gross IPO proceeds $115,000,000 IPO completed June 26, 2026
going concern financial
"substantial doubt exists about the Company’s ability to continue as a going concern"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
temporary equity financial
"Public Class A shares are presented in temporary equity"
Equity-like securities that accounting rules require to be reported separately from permanent shareholders’ equity because the holder can force or the issuer is obligated to settle them in cash or other assets (or they will be settled on a specified date). Examples include mandatorily redeemable shares and certain convertible instruments with required cash settlement; on the balance sheet they appear between liabilities and shareholders’ equity (often called mezzanine or temporary equity) rather than as part of common equity.
two-class method financial
"Under the two-class method, net income is allocated pro rata"
deferred underwriting commission financial
"The $805,000 deferred underwriting commission is payable from the Trust Account"
Level 1 inputs financial
"Trust Account is invested in quoted money market fund holdings measured using Level 1 inputs"
Working Capital Loans financial
"the aggregate principal amount capped at $3,000,000"
Working capital loans are short-term loans companies use to cover everyday operational expenses—such as payroll, inventory purchases, or utility bills—when incoming cash is delayed or uneven. Investors care because frequent or growing reliance on these loans can signal ongoing cash-flow stress and higher financial risk, while occasional use can simply smooth predictable ups and downs; like a household using a short-term loan to bridge paychecks, it affects a company’s short-term stability and flexibility.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What was ALPX’s net income for the third quarter of 2026?

ALPX reported $924,086 in net income for the three months ended September 30, 2026. Trust investment income was $1,038,267 and operating expenses were $118,072; the company had not generated operating revenue.

How much cash did ALPX have outside its Trust Account?

At September 30, 2026, ALPX had $282,656 in cash outside its Trust Account. The Trust Account held $116,070,637, which the company said was restricted and generally unavailable for ordinary operating expenses.

What is the status of ALPX’s potential business combination?

In November 2026, ALPX entered a non-binding letter of intent with a prospective target. It remains subject to due diligence, negotiation and execution of definitive agreements, and applicable approvals; certain confidentiality, exclusivity and expense provisions are binding.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
00-0000000 http://fasb.org/srt/2026#ChiefExecutiveOfficerMember 0002125551 false Q3 --12-31 0002125551 2026-07-01 2026-09-30 0002125551 2026-01-01 2026-09-30 0002125551 2026-09-30 0002125551 2026-01-05 2026-09-30 0002125551 us-gaap:FairValueInputsLevel1Member 2026-09-30 0002125551 alpxu:PrivateRightsMember 2026-09-30 0002125551 alpxu:PublicRightsMember 2026-09-30 0002125551 us-gaap:WarrantMember 2026-09-30 0002125551 alpxu:PrivatePlacementWarrantsMember 2026-09-30 0002125551 alpxu:PublicWarrantsMember 2026-09-30 0002125551 us-gaap:RetainedEarningsMember 2026-07-01 2026-09-30 0002125551 us-gaap:AdditionalPaidInCapitalMember 2026-07-01 2026-09-30 0002125551 alpxu:RedemptionValueMember 2026-07-01 2026-09-30 0002125551 alpxu:RedeemableClassAOrdinarySharesMember 2026-09-30 0002125551 alpxu:RedeemableClassAOrdinarySharesMember 2026-07-01 2026-09-30 0002125551 alpxu:RedeemableClassAOrdinarySharesMember 2026-06-30 0002125551 us-gaap:CommonClassBMember alpxu:FounderShareMember 2026-09-30 0002125551 alpxu:NonRedeemableClassAOrdinarySharesMember 2026-09-30 0002125551 alpxu:RedeemableClassAOrdinarySharesMember 2026-09-30 0002125551 us-gaap:CommonClassBMember 2026-09-30 0002125551 us-gaap:CommonClassAMember 2026-09-30 0002125551 alpxu:UnderwritingAgreementMember 2026-09-30 0002125551 alpxu:RobinsonAndColeLLPMember 2026-09-30 0002125551 alpxu:UnderwritingAgreementMember alpxu:RobinsonAndColeLLPMember 2026-01-05 2026-09-30 0002125551 alpxu:UnderwritingAgreementMember 2026-01-05 2026-09-30 0002125551 us-gaap:IPOMember alpxu:UnderwritingAgreementMember 2026-09-30 0002125551 us-gaap:IPOMember alpxu:UnderwritingAgreementMember 2026-01-05 2026-09-30 0002125551 alpxu:BusinessCombinationMember 2026-09-30 0002125551 alpxu:BusinessCombinationMember 2026-01-05 2026-09-30 0002125551 alpxu:SponsorMember alpxu:BusinessCombinationMember 2026-01-05 2026-09-30 0002125551 alpxu:SponsorNoteAndExecutiveCompensationMember 2026-07-01 2026-09-30 0002125551 srt:ChiefFinancialOfficerMember 2026-01-05 2026-09-30 0002125551 srt:ChiefExecutiveOfficerMember 2026-01-05 2026-09-30 0002125551 us-gaap:RelatedPartyMember 2026-09-30 0002125551 alpxu:SponsorNoteAndExecutiveCompensationMember 2026-09-30 0002125551 alpxu:SecuritiesTransferAgreementMember 2026-07-01 2026-09-30 0002125551 alpxu:SecuritiesTransferAgreementMember alpxu:BusinessCombinationMember 2026-06-24 2026-06-24 0002125551 us-gaap:CommonClassBMember alpxu:SecuritiesTransferAgreementMember alpxu:BusinessCombinationMember alpxu:ThreeIndependentDirectorsMember 2026-06-24 2026-06-24 0002125551 alpxu:SponsorMember 2026-01-05 2026-09-30 0002125551 us-gaap:OverAllotmentOptionMember alpxu:SponsorMember alpxu:FounderShareMember 2026-01-05 2026-09-30 0002125551 us-gaap:CommonClassBMember alpxu:SponsorMember 2026-01-05 2026-09-30 0002125551 alpxu:SponsorMember alpxu:FounderShareMember 2026-01-05 2026-09-30 0002125551 alpxu:PromissoryNoteMember 2026-01-05 2026-09-30 0002125551 alpxu:TrustAccountMember 2026-01-05 2026-09-30 0002125551 us-gaap:PrivatePlacementMember 2026-01-05 2026-09-30 0002125551 us-gaap:PrivatePlacementMember 2026-09-30 0002125551 us-gaap:PrivatePlacementMember 2026-06-26 2026-06-26 0002125551 us-gaap:IPOMember 2026-06-26 0002125551 2026-06-26 2026-06-26 0002125551 us-gaap:CommonClassAMember 2026-06-26 0002125551 alpxu:PublicWarrantMember 2026-06-26 2026-06-26 0002125551 us-gaap:CommonClassAMember 2026-06-26 2026-06-26 0002125551 us-gaap:IPOMember 2026-06-26 2026-06-26 0002125551 us-gaap:CommonClassAMember us-gaap:IPOMember 2026-06-26 2026-06-26 0002125551 alpxu:ClassBNon-redeemableMember 2026-01-05 2026-09-30 0002125551 alpxu:NonRedeemableClassAOrdinarySharesMember 2026-01-05 2026-09-30 0002125551 alpxu:RedeemableClassAOrdinarySharesMember 2026-01-05 2026-09-30 0002125551 alpxu:ClassBNon-redeemableMember 2026-07-05 2026-09-30 0002125551 alpxu:NonRedeemableClassAOrdinarySharesMember 2026-07-05 2026-09-30 0002125551 alpxu:RedeemableClassAOrdinarySharesMember 2026-07-05 2026-09-30 0002125551 us-gaap:CommonClassAMember 2026-01-05 2026-09-30 0002125551 2026-06-26 0002125551 us-gaap:OverAllotmentOptionMember 2026-06-26 2026-06-26 0002125551 us-gaap:RetainedEarningsMember 2026-09-30 0002125551 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2026-09-30 0002125551 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2026-09-30 0002125551 2026-06-30 0002125551 us-gaap:RetainedEarningsMember 2026-06-30 0002125551 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0002125551 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2026-06-30 0002125551 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2026-06-30 0002125551 2026-04-01 2026-06-30 0002125551 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0002125551 us-gaap:ReceivablesFromStockholderMember 2026-04-01 2026-06-30 0002125551 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2026-04-01 2026-06-30 0002125551 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0002125551 2026-03-31 0002125551 us-gaap:ReceivablesFromStockholderMember 2026-03-31 0002125551 us-gaap:RetainedEarningsMember 2026-03-31 0002125551 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0002125551 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2026-03-31 0002125551 2026-01-05 2026-03-31 0002125551 us-gaap:RetainedEarningsMember 2026-01-05 2026-03-31 0002125551 us-gaap:ReceivablesFromStockholderMember 2026-01-05 2026-03-31 0002125551 us-gaap:AdditionalPaidInCapitalMember 2026-01-05 2026-03-31 0002125551 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2026-01-05 2026-03-31 0002125551 us-gaap:CommonClassBMember 2026-01-05 2026-01-05 0002125551 alpxu:NonRedeemableClassBOrdinarySharesMember 2026-01-05 2026-09-30 0002125551 alpxu:NonRedeemableClassBOrdinarySharesMember 2026-07-01 2026-09-30 0002125551 alpxu:NonRedeemableClassAOrdinarySharesMember 2026-07-01 2026-09-30 0002125551 alpxu:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2026-01-05 2026-09-30 0002125551 alpxu:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2026-07-01 2026-09-30 0002125551 us-gaap:CommonClassBMember 2026-11-20 0002125551 us-gaap:CommonClassAMember 2026-11-20 0002125551 alpxu:RightsEachWholeRightToAcquireOnefourthOfOneClassAOrdinaryShareMember 2026-01-01 2026-09-30 0002125551 alpxu:RedeemableWarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150Member 2026-01-01 2026-09-30 0002125551 alpxu:ClassAOrdinarySharesParValue00001PerShareMember 2026-01-01 2026-09-30 0002125551 alpxu:UnitsConsistingOfOneClassAOrdinaryShare00001ParValueOneRedeemableWarrantToAcquireOneClassAOrdinaryShareAndOneRightToAcquireOnefourthOfOneClassAOrdinaryShareMember 2026-01-01 2026-09-30 0002125551 us-gaap:FairValueInputsLevel2Member 2026-09-30 0002125551 us-gaap:FairValueInputsLevel3Member 2026-09-30 0002125551 2026-03-15 0002125551 2026-01-04 0002125551 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2026-01-04 0002125551 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2026-01-04 0002125551 us-gaap:AdditionalPaidInCapitalMember 2026-01-04 0002125551 us-gaap:RetainedEarningsMember 2026-01-04 0002125551 us-gaap:ReceivablesFromStockholderMember 2026-01-04 0002125551 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2026-01-05 2026-03-31 0002125551 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2026-04-01 2026-06-30 0002125551 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2026-03-31 0002125551 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2026-07-01 2026-09-30 0002125551 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2026-07-01 2026-09-30 0002125551 us-gaap:ReceivablesFromStockholderMember 2026-07-01 2026-09-30 0002125551 us-gaap:ReceivablesFromStockholderMember 2026-06-30 0002125551 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0002125551 us-gaap:ReceivablesFromStockholderMember 2026-09-30 iso4217:USD alpxu:Segments iso4217:USD xbrli:shares xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2026

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _________ to __________

 

Commission File Number 001-43369

 

Alpex Acquisition Corporation

(Exact name of registrant as specified in its charter)

 

Cayman Islands   N/A
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification Number)

 

300 Delaware Ave. Suite 210 #494

Wilmington, DE 19801 (Address of principal executive offices and zip code)

 

(302) 251-6637 (Registrant’s telephone number, including area code)

 

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol   Name of each exchange on which registered
Units, consisting of one Class A ordinary share, $0.0001 par value, one redeemable Warrant to acquire one Class A ordinary share, and one Right to acquire one-fourth of one Class A ordinary share   ALPXU   The Nasdaq Stock Market LLC
Class A ordinary shares, par value $0.0001 per share   ALPX   The Nasdaq Stock Market LLC
Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50   ALPXW   The Nasdaq Stock Market LLC
Rights, each whole right to acquire one-fourth of one Class A ordinary share   ALPXR   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☒ Smaller reporting company ☒
    Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

 

As of November 20, 2026, there were 11,917,500 of the registrant’s Class A ordinary shares, par value $0.0001 per share, and 2,875,000 of the registrant’s Class B ordinary shares, par value $0.0001 per share, issued and outstanding.

 

 

 

 

 

 

Alpex Acquisition Corporation

 

TABLE OF CONTENTS

 

PART I – FINANCIAL INFORMATION 1
Item 1. FINANCIAL STATEMENTS (UNAUDITED) 1
Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 13
Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 15
Item 4. CONTROLS AND PROCEDURES 15
PART II – OTHER INFORMATION 16
Item 1. LEGAL PROCEEDINGS 16
Item 1A. RISK FACTORS 16
Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS FROM REGISTERED SECURITIES 16
Item 3. DEFAULTS UPON SENIOR SECURITIES 16
Item 4. MINE SAFETY DISCLOSURES 16
Item 5. OTHER INFORMATION 16
Item 6. EXHIBITS 16
SIGNATURES 17

 

i

 

 

PART I – FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

ALPEX ACQUISITION CORPORATION

 

UNAUDITED CONDENSED BALANCE SHEET

 

September 30, 2026 (Unaudited)

 

    September 30,
2026
 
ASSETS      
Current assets      
Cash and cash equivalents     282,656  
Prepaid expenses     466,781  
Total current assets     749,437  
Cash and marketable securities held in trust account     116,070,637  
Total assets     116,820,074  
         
LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT        
Current liabilities        
Accrued expenses and other current liabilities     17,000  
Promissory note – related party     209,653  
Total current liabilities     226,653  
Deferred underwriting fee payable     805,000  
Total liabilities     1,031,653  
         
Commitments and contingencies (Note 6)        
Class A ordinary shares subject to possible redemption, $0.0001 par value; 11,500,000 shares at initial redemption value of $10.00 per share, as adjusted for Trust Account earnings     116,070,637  
         
Shareholders’ deficit        
Preference shares, $0.0001 par; 10,000,000 authorized; none outstanding     -  
Class A ordinary shares, $0.0001 par; 400,000,000 authorized; 417,500 non-redeemable shares outstanding     42  
Class B ordinary shares, $0.0001 par; 90,000,000 authorized; 2,875,000 shares outstanding     288  
Additional paid-in capital     -  
Accumulated deficit     (282,546 )
Total shareholders’ deficit     (282,216 )
Total liabilities, Class A ordinary shares subject to possible redemption and shareholders’ deficit     116,820,074  

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

1

 

ALPEX ACQUISITION CORPORATION

 

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS

 

Amounts in U.S. dollars, except shares and per-share data

 

    Three months
ended
September 30,
2026
    January 5,
2026
(inception)
through
September 30,
2026
 
Formation and operating costs     (118,072 )     (334,956 )
Share-based compensation     -       (64,401 )
Total Operating Loss     (118,072 )     (399,357 )
Interest income on cash and cash equivalents     3,890       5,160  
Interest income on marketable securities held in trust account     1,038,267       1,070,637  
Net income     924,086       676,441  
                 
Basic and diluted weighted-average shares outstanding, Class A ordinary shares subject to possible redemption     11,500,000       4,146,840  
Basic net income per share, Class A ordinary shares subject to possible redemption   $ 0.06     $ 0.10  
Diluted net income per share, Class A ordinary shares subject to possible redemption   $ 0.06     $ 0.10  
Basic and diluted weighted-average shares outstanding, non-redeemable Class A ordinary shares     417,500       150,548  
Basic net income per share, non-redeemable Class A ordinary shares   $ 0.06     $ 0.10  
Diluted net income per share, non-redeemable Class A ordinary shares   $ 0.06     $ 0.10  
Basic weighted-average shares outstanding, non-redeemable Class B ordinary shares (1)     2,875,000       2,635,223  
Basic net income per share, non-redeemable Class B ordinary shares   $ 0.06     $ 0.10  
Diluted weighted-average shares outstanding, non-redeemable Class B ordinary shares     2,875,000       2,755,112  
Diluted net income per share, non-redeemable Class B ordinary shares   $ 0.06     $ 0.10  

 

(1) For the period from January 5, 2026 (inception) through September 30, 2026, basic weighted-average Class B ordinary shares exclude 375,000 shares for the portion of the period during which those shares were subject to forfeiture. The shares ceased to be subject to forfeiture on June 26, 2026, when the underwriters fully exercised their over-allotment option. The Company was incorporated on January 5, 2026 and had no corresponding operating periods in 2025. See Note 2 for the calculation of basic and diluted earnings per share.

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

2

 

ALPEX ACQUISITION CORPORATION

 

UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT

 

January 5, 2026 (inception) through September 30, 2026

 

    Ordinary shares     Additional           Share     Total  
    Class A     Class B     Paid-in     Accumulated     subscription     Shareholders’  
    Shares     Amount     Shares     Amount     Capital     deficit     Receivable     deficit  
Balance, January 5, 2026 (inception)     -       -       -       -       -       -       -       -  
Class B ordinary shares issued to Sponsor     -       -       2,875,000       288       24,712       -       (25,000 )     -  
Net loss     -       -       -       -       -       (59,856 )     -       (59,856 )
Balance as of March 31, 2026     -       -       2,875,000       288       24,712       (59,856 )     (25,000 )     (59,856 )
Net loss     -       -       -       -       -       (187,789 )     -       (187,789 )
Issuance of representative shares     230,000       23       -       -       251,690       -       -       251,713  
Sales of private placement units     187,500       19       -       -       1,874,981       -       -       1,875,000  
Issuance of Public Rights     -       -       -       -       3,114,627       -       -       3,114,627  
Issuance of Public Warrants     -       -       -       -       209,044       -       -       209,044  
Offering costs allocated to equity-classified instruments     -       -       -       -       (68,217 )     -       -       (68,217 )
Capital contribution from Sponsor     -       -       -       -       1,000       -       -       1,000  
Accretion of Class A ordinary shares subject to possible redemption to initial redemption value     -       -       -       -       (5,360,588 )     -       -       (5,360,588 )
Remeasurement of Class A ordinary shares subject to possible redemption for Trust Account earnings     -       -       -       -       (32,370 )     -       -       (32,370 )
Collection of share capital receivable     -       -       -       -       -       -       25,000       25,000  
Sponsor contribution for director services     -       -       -       -       64,401       -       -       64,401  
Balance as of June 30, 2026     417,500       42       2,875,000       288       79,281       (247,645 )     -       (168,035 )
Redemption-value adjustment     -       -       -       -       (79,281 )     (958,986 )     -       (1,038,267 )
Net income     -       -       -       -       -       924,086       -       924,086  
Balance as of September 30, 2026     417,500       42       2,875,000       288       -       (282,546 )     -       (282,216 )

 

Class A share counts above exclude 11,500,000 redeemable public shares. Founder shares are presented retrospectively, consistent with the prior filing. Dollar amounts are rounded; totals may differ due to rounding.

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

3

 

ALPEX ACQUISITION CORPORATION

 

UNAUDITED CONDENSED STATEMENT OF CASH FLOWS

 

January 5, 2026 (inception) through September 30, 2026

 

    Amount  
Cash Flows from Operating Activities:      
Net income     676,441  
Adjustments to reconcile net income to net cash used in operating activities:        
Formation and operating costs paid by Sponsor     92,925  
Deferred offering cost written off to expense     5,000  
Income earned on investments held in the Trust Account     (1,070,637 )
Noncash share-based compensation     64,401  
Changes in operating assets and liabilities:        
Prepaid expenses     (466,781 )
Accrued liabilities and other payables     7,625  
Net cash used in operating activities     (691,026 )
         
Cash Flows from Investing Activities:        
Cash invested in trust account     (115,000,000 )
Net cash used in investing activities     (115,000,000 )
         
Cash Flows from Financing Activities:        
Sponsor cash contribution     1,000  
Gross proceeds from IPO     115,000,000  
Cash proceeds from private placement     1,800,000  
Offering costs paid     (827,318 )
Net cash provided by financing activities     115,973,682  
         
Net increase in cash and cash equivalents     282,656  
Cash and cash equivalents at beginning of period     -  
Cash and cash equivalents at end of period     282,656  
         
Supplemental disclosure of non-cash financing activities:        
Deferred offering costs paid by Sponsor and included in Promissory Note     226,103  
Deferred underwriting fee accrued and charged to additional paid-in capital     805,000  
Private placement and founder share subscription amounts settled against Promissory Note     100,000  
Representative shares issued as non-cash underwriting compensation     251,713  
Sponsor contribution through share-based compensation     64,401  
Promissory Note reclassified to accrued compensation     9,375  
Trust-earnings redemption-value accretion     1,070,637  

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

4

 

ALPEX ACQUISITION CORPORATION

 

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

September 30, 2026

 

NOTE 1 ORGANIZATION OPERATIONS AND GOING CONCERN

 

Alpex Acquisition Corporation (the “Company”) was incorporated in the Cayman Islands on January 5, 2026. It is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (a “Business Combination”). Hugreat Ltd, a British Virgin Islands business company with limited liability, is the Company’s sponsor (the “Sponsor”). The Company has a December 31 fiscal year end. The Company had not completed a Business Combination or commenced revenue-producing operations as of September 30, 2026.

 

On June 26, 2026, the Company completed its initial public offering (the “Initial Public Offering”) of 11,500,000 units, including the full exercise of the underwriters’ over-allotment option, generating gross proceeds of $115,000,000. Concurrently, the Company completed a private placement of 187,500 units to the Sponsor, generating $1,800,000 in cash and a $75,000 offset against Sponsor advances. The Company also issued 230,000 representative shares to the underwriter and/or its designees as non-cash underwriting compensation.

 

Following the closing of the Initial Public Offering, $115,000,000 was deposited into a U.S.-based trust account (the “Trust Account”) maintained by Equiniti Trust Company, LLC, as trustee. The funds in the Trust Account may be invested in U.S. government treasury obligations with a maturity of 185 days or less, in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended, or held in cash or an interest-bearing demand deposit account, until the earlier of the completion of a Business Combination or the distribution of the Trust Account.

 

The Company must complete a Business Combination by June 26, 2027, unless the period is extended in accordance with its governing documents. If the Company is unable to complete a Business Combination within the applicable period, it will cease operations except for the purpose of winding up, redeem the Public Shares using the funds then held in the Trust Account, including interest earned thereon, net of taxes payable and permitted dissolution expenses, and thereafter liquidate, subject to applicable law and the Company’s obligations to creditors.

 

The Sponsor and the Company’s officers and directors have agreed to waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares and the Class A ordinary shares included in the Private Placement Units if the Company does not complete a Business Combination within the applicable period. Such waiver does not apply to any Public Shares that the Sponsor, officers or directors may acquire, with respect to which they retain the applicable redemption rights.

 

As described in the IPO prospectus, the Sponsor agreed to indemnify the Company for certain claims that reduce the funds held in the Trust Account, subject to the applicable limitations and exceptions.

  

As of September 30, 2026, the Company had $282,656 in cash held outside the Trust Account, $466,781 in prepaid expenses, current liabilities of $226,653 and $116,070,637 held in the Trust Account. Net cash used in operating activities from January 5, 2026 (inception) through September 30, 2026 was $691,026.

 

The funds held in the Trust Account are restricted and are generally unavailable to fund the Company’s ordinary operating expenses. The Company expects to continue incurring significant costs in identifying, evaluating and completing a Business Combination and in meeting its public company reporting and compliance obligations.

 

Management may seek additional financing from the Sponsor or third parties, including through working capital loans. However, there can be no assurance that such financing will be available when needed or that the Company will complete a Business Combination within the required period.

 

Management concluded that substantial doubt exists about the Company’s ability to continue as a going concern for one year after the date these unaudited condensed financial statements are issued. Management’s plans do not alleviate the substantial doubt. Accordingly, the accompanying financial statements have been prepared on a going-concern basis and do not include any adjustments that might result from the outcome of this uncertainty.

 

5

 

ALPEX ACQUISITION CORPORATION

 

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

September 30, 2026

 

NOTE 2 SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying unaudited financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”). The financial information provided is unaudited but includes all adjustments which management considers necessary for the fair presentation of the results for the period.

 

Emerging Growth Company

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). The Company has elected to use the extended transition period for complying with new or revised accounting standards under Section 107(b) of the JOBS Act.

 

Accordingly, the Company may adopt new or revised accounting standards at the effective dates applicable to private companies when those dates differ from the effective dates applicable to public business entities. As a result, the Company’s financial statements may not be comparable to those of public companies that have not elected to use the extended transition period.

 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the financial statement date, and the reported amounts of expenses and other income during the reporting period. Actual results could differ from those estimates.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. Cash and cash equivalents were $754,952 and nil as of June 30, 2026 and March 15, 2026. Cash and cash equivalents are maintained at financial institutions and may, at times, exceed federally insured limits.

 

Cash and marketable securities held in Trust Account

 

As of September 30, 2026, substantially all of the assets held in the Trust Account were held in a money market fund that invests solely in U.S. Treasury securities. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from changes in the fair value of investments held in the Trust Account are included in investment income earned on marketable securities held in the Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. The Company had $116,070,637 of investments held in the Trust Account as of September 30, 2026.

 

Offering Costs Associated with the Initial Public Offering

 

The Company accounts for offering costs in accordance with ASC 340-10-S99 and SEC Staff Accounting Bulletin Topic 5.A, “Expenses of Offering.” These costs consist principally of professional and registration fees directly attributable to the Initial Public Offering. The Company allocated the proceeds from the Units using the residual method under ASC 470-20. Proceeds were allocated first to the assigned values of the warrants and rights, with the remainder allocated to the Class A ordinary shares.

 

Offering costs attributable to the Public Shares were charged to temporary equity. Costs attributable to the warrants and rights included in the Units, the Private Placement Units and the Representative Shares were charged to shareholders’ deficit. The Company accounts for the Public and Private Placement Rights under ASC 815 and the Public and Private Placement Warrants under ASC 815-40. The rights and warrants qualify for equity classification, were recorded at their assigned values upon issuance and are not subsequently remeasured.

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.

 

6

 

ALPEX ACQUISITION CORPORATION

 

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

September 30, 2026

 

NOTE 2 SIGNIFICANT ACCOUNTING POLICIES CONTINUED

 

Class A Ordinary Shares Subject to Possible Redemption

 

Public Class A shares are presented in temporary equity because their redemption is outside the Company’s sole control. The Company adjusts them to the applicable redemption value, charging available APIC and then accumulated deficit. Such adjustments do not enter net income. Public and private rights and warrants remain equity-classified under the Company’s instrument-specific ASC 815-40 assessment and are not subsequently marked to market.

 

Share-based compensation

 

Equity awards provided by a shareholder for services to the Company are recognized under ASC 718 as compensation expense and a capital contribution. Compensation reflects grant-date fair value less consideration paid by the service provider. The independent-director award is described in Note 5.

 

Income Tax

 

The Company accounts for income taxes under ASC 740. The Company is not subject to income tax in the Cayman Islands and had no taxable nexus in another jurisdiction during the periods presented. Accordingly, no income tax expense was recognized. ASU 2023-07 was adopted at formation. Management does not expect any recently issued accounting standards not yet adopted to have a material effect on the Company’s financial statements.

 

Fair Value Measurements

 

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

 

  ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
     
  ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
     
  ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

 

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

 

Fair Value of Financial Instruments

 

The carrying amounts of the Company’s financial assets and liabilities, other than investments held in the Trust Account, approximate their fair values primarily due to their short-term nature. Investments held in the Trust Account are measured at fair value on a recurring basis.

 

Net Income Per Ordinary Share

 

The Company has two classes of ordinary shares, Class A ordinary shares and Class B ordinary shares. Under the two-class method, net income is allocated pro rata among redeemable Class A ordinary shares, non-redeemable Class A ordinary shares and Class B ordinary shares. Net income per ordinary share is calculated by dividing the income allocated to each group by its weighted-average shares outstanding for the period. Accretion and remeasurement of Class A ordinary shares subject to possible redemption are excluded from the earnings-per-share calculation because their redemption value approximates fair value.

 

The forfeiture condition on 375,000 Founder Shares was satisfied on June 26, 2026, when the underwriters fully exercised their over-allotment option. These shares are included in basic earnings per share from that date and in diluted earnings per share for the period from inception through September 30, 2026 on a weighted-average basis beginning April 1, 2026.

 

The public and private placement rights and warrants were excluded from diluted earnings per share because the initial Business Combination had not been completed as of September 30, 2026. The rights represented 2,921,875 potential Class A ordinary shares, and the warrants represented 11,687,500 potential Class A ordinary shares.

 

7

 

ALPEX ACQUISITION CORPORATION

 

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

September 30, 2026

 

The following tables reconcile the numerators and denominators used to calculate basic and diluted net income per ordinary share.

 

    Three Months Ended  
    September 30, 2026  
    Class A 
Redeemable
    Class A
Non-redeemable
    Class B 
Non-redeemable
 
Basic net income per ordinary share:                  
Numerator:                  
Allocation of net income, basic   $ 718,404     $ 26,081     $ 179,601  
Denominator:                        
Basic weighted-average ordinary shares outstanding     11,500,000       417,500       2,875,000  
Basic net income per ordinary share   $ 0.06     $ 0.06     $ 0.06  
                         
Diluted net income per ordinary share:                        
Numerator:                        
Allocation of net income, diluted   $ 718,404     $ 26,081     $ 179,601  
Denominator:                        
Diluted weighted average ordinary shares outstanding     11,500,000       417,500       2,875,000  
Diluted net income per ordinary share   $ 0.06     $ 0.06     $ 0.06  

 

   

For the Period from January 5, 2026

(inception) through

 
    September 30, 2026  
    Class A
Redeemable
    Class A
Non-redeemable
    Class B
Non-redeemable
 
Basic net income per ordinary share:                  
Numerator:                  
Allocation of net income, basic   $ 404,623     $ 14,689     $ 257,129  
Denominator:                        
Basic weighted average ordinary shares outstanding     4,146,840       150,548       2,635,223  
Basic net income per ordinary share   $ 0.10     $ 0.10     $ 0.10  
                         
Diluted net income per ordinary share:                        
Numerator:                        
Allocation of net income, diluted   $ 397,744     $ 14,440     $ 264,257  
Denominator:                        
Diluted weighted average ordinary shares outstanding     4,146,840       150,548       2,755,112  
Diluted net income per ordinary share   $ 0.10     $ 0.10     $ 0.10  

 

Recent Accounting Pronouncements

 

In November 2023, the Financial Accounting Standards Board (“FASB”) issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,” which expands annual and interim disclosures regarding significant segment expenses, other segment items and the role of the chief operating decision maker. The Company adopted ASU 2023-07 upon incorporation. The adoption resulted in additional disclosures and did not have a material effect on the Company’s financial statements.

 

In November 2024, the FASB issued ASU 2024-03, “Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses,” and in January 2025 issued ASU 2025-01 to clarify the effective date. The guidance requires additional disclosures about the nature of expenses included in income statement captions. The guidance is effective for annual periods beginning after December 15, 2026 and interim periods beginning after December 15, 2027, with early adoption permitted. The Company is evaluating the impact of the guidance and does not expect adoption to have a material effect on its financial statements. Management does not believe that any other recently issued, but not yet effective, accounting standards would have a material effect on the Company’s financial statements if adopted currently.

 

8

 

ALPEX ACQUISITION CORPORATION

 

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

September 30, 2026

 

NOTE 3 INITIAL PUBLIC OFFERING

 

On June 26, 2026, the Company completed its Initial Public Offering of 11,500,000 units at $10.00 per unit, including 1,500,000 units sold upon full exercise of the underwriters’ over-allotment option, for gross proceeds of $115,000,000. Each unit consisted of one Class A ordinary share, one right to receive one-fourth of one Class A ordinary share upon completion of the initial Business Combination, and one redeemable warrant.

 

Each whole warrant entitles the holder to purchase one Class A ordinary share at $11.50, subject to adjustment. The warrants become exercisable on the later of 30 days after completion of the initial Business Combination and 12 months after the effective date of the IPO registration statement. They expire five years after completion of the initial Business Combination, or earlier upon redemption or liquidation. No fractional shares will be issued upon conversion of the rights. The rights expire worthless if the Company does not complete a Business Combination within the prescribed period.

 

NOTE 4 PRIVATE PLACEMENT

 

At the IPO closing, Hugreat Ltd, the Company’s Sponsor, purchased 187,500 Private Placement Units at $10.00 per unit for an aggregate purchase price of $1,875,000. Of that amount, $1,800,000 was deposited into the Trust Account and $75,000 was applied against the Sponsor promissory note.

 

Each Private Placement Unit consisted of one Class A ordinary share, one right and one warrant. The Private Placement Units and their underlying securities are subject to the terms and transfer restrictions set forth in the applicable agreements. If the Company does not complete a Business Combination within the prescribed period, the Private Placement Rights and Warrants will expire worthless, and the Private Placement Shares will not participate in liquidating distributions from the Trust Account.

 

NOTE 5 RELATED PARTY TRANSACTIONS AND DIRECTOR SHARE COMPENSATION

 

Founder shares and independent-director awards

 

The Sponsor’s Founder Share purchase comprised 2,875,000 Class B shares for $25,000. All 375,000 shares originally subject to over-allotment forfeiture became nonforfeitable following the full exercise at IPO. The $25,000 subscription balance was settled against Sponsor advances.

 

The Sponsor transferred 60,000 existing Class B shares to three independent directors for $600 in total. For the period from inception through September 30, 2026, the Company recognized $64,401 of share-based compensation and a corresponding Sponsor capital contribution, measured at grant-date fair value less the consideration paid.

 

Promissory Note - Related Party and executive compensation

 

The balance of the promissory note payable to the Sponsor (the “Promissory Note”) at September 30, 2026 was $209,653. During the quarter, $9,375 was reclassified from the Promissory Note to accrued executive compensation without cash payment. No interest was recorded on the note. The Promissory Note permits borrowings of up to $500,000 for IPO-related expenditures, is non-interest-bearing and was payable on the earlier of December 31, 2027 or the consummation of the Initial Public Offering. As of September 30, 2026, $209,653 remained outstanding.

 

CEO and CFO compensation was limited to six months of monthly payments of $7,500 and $5,000, respectively, for a total cap of $75,000. Compensation expense for the quarter was $9,166 and cumulative compensation was $75,000. The quarter’s reclassification of $9,375 is not an additional compensation expense. At September 30, 2026, accrued expenses totaled $17,000.

 

Working capital loans

 

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”), with the aggregate principal amount capped at $3,000,000. If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company, and up to $3,000,000 of such loans may be converted into private units (as described in Note 4) at $10.00 per unit at the lender’s discretion. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The terms of such Working Capital Loans, if any, other than the aforesaid principal amount limit and conversion right, have not been determined and no written agreements exist with respect to such loans. As of September 30, 2026, no Working Capital Loans were outstanding.

 

9

 

ALPEX ACQUISITION CORPORATION

 

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

September 30, 2026

 

NOTE 6 COMMITMENTS AND CONTINGENCIES

 

Underwriting and registration arrangements

 

The Company paid a cash underwriting commission of $575,000 upon closing of the Initial Public Offering. Under the Underwriting Agreement, the $805,000 deferred underwriting commission is payable from the Trust Account upon completion of the initial Business Combination. If the Company does not complete a Business Combination and the Trust Account is liquidated, the underwriters will forfeit the deferred commission. The Company also issued 230,000 representative shares valued at $251,713. The deferred commission remained unpaid at September 30, 2026. Existing registration rights, indemnities and transfer restrictions remain governed by the IPO agreements.

 

During September 2026, the Company paid $300,000 to USMART Securities SG Pte for financial-advisory services under the agreement dated September 21, 2026, and $75,000 to Robinson & Cole LLP as the initial payment under the legal engagement letter. The advisory fee was recorded as a prepayment and is recognized as expense as the services are received. The engagement ends upon completion of the services or 12 months after execution of the agreement, whichever occurs first. Advisory expense of $8,219 was recognized for September 21–30, 2026, leaving $291,781 in prepaid expenses at September 30, 2026. The initial legal payment was included in prepaid expenses at September 30, 2026. Both payments were made from non-trust funds and are included in operating cash flows. The de-SPAC engagement letter provides for aggregate fees of $800,000, of which $75,000 has been paid. Remaining milestone payments include $75,000 upon execution of definitive agreements, $100,000 upon the first filing of the registration statement, $30,000 for each subsequent amendment, $50,000 upon receipt of SEC verbal clearance, and the balance upon completion of the Business Combination. If the Company terminates the financial advisory agreement before the end of its term, it must pay a $50,000 termination fee plus incurred out-of-pocket expenses. If the Business Combination is terminated, legal fees for completed milestones remain payable, and fees for work on the pending milestone are limited to the lesser of discounted hourly fees or the fixed fee for that milestone.

 

NOTE 7 SHAREHOLDERS’ DEFICIT AND REDEEMABLE SHARES

 

The authorized capital comprises 10,000,000 preference shares, 400,000,000 Class A ordinary shares and 90,000,000 Class B ordinary shares, each with $0.0001 par value. At September 30, 2026, no preference shares were issued. Outstanding shares comprised 11,500,000 redeemable Class A shares, 417,500 non-redeemable Class A shares and 2,875,000 Class B shares. The existing Founder Share conversion provisions continue to apply. The director compensation entry does not change outstanding shares.

 

Redeemable Class A carrying amount   Amount  
Balance, June 30, 2026     115,032,370  
Trust-earnings redemption-value increase in Q3     1,038,267  
Balance, September 30, 2026     116,070,637  

 

Of the quarter’s $1,038,267 redemption-value increase, $79,281 reduced additional paid-in capital and $958,986 increased accumulated deficit. The APIC amount includes capital contributed through the director award in the prior quarter. The remeasurement affects equity, not the statement of operations. The historical initial IPO allocation and accretion have not been revised in this interim presentation.

 

Warrants and rights

 

At September 30, 2026, 11,500,000 public warrants and 187,500 private warrants were outstanding. A whole warrant entitles its holder to one Class A share at $11.50, subject to contractual adjustments. Exercise begins on the later of 30 days after a business combination or 12 months after registration effectiveness. Warrants generally expire five years after the combination, subject to earlier termination. Public-warrant redemption is subject to the price, notice and registration conditions in the Warrant Agreement. The Private Warrants are identical to the Public Warrants, except for the transfer restrictions and permitted-transfer provisions described in the Warrant Agreement. No warrant exercise is recorded for the quarter.

 

The 11,500,000 public and 187,500 private rights each entitle their holder to one-fourth of a Class A share upon a qualifying combination. Rights have no liquidation claim and lapse without a qualifying transaction. No right conversion is recorded for the quarter.

 

10

 

ALPEX ACQUISITION CORPORATION

 

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

September 30, 2026

 

NOTE 8 FAIR VALUE MEASUREMENTS

 

The Trust Account is invested in quoted money market fund holdings measured using Level 1 inputs. Its September 30, 2026 fair value was $116,070,637. The director award uses an ASC 718 grant-date valuation with significant unobservable assumptions; it is not included as an asset or liability in the recurring fair-value table.

 

Recurring fair-value asset   Level 1     Level 2     Level 3     Total  
Trust investments     116,070,637       -       -       116,070,637  

 

The carrying amount of accrued payables approximates fair value due to their short-term nature.

 

NOTE 9 SEGMENT INFORMATION

 

ASC Topic 280, “Segment Reporting,” establishes standards for companies to report in their financial statement information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by the Company’s chief operating decision maker, or group, in deciding how to allocate resources and assess performance.

 

The Company’s chief operating decision maker has been identified as the Chief Executive Officer (“CODM”), who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one operating segment.

 

The CODM assesses performance for the single segment and decides how to allocate resources based on net loss that also is reported on the unaudited statements of operations as net loss. The measure of segment assets is reported on the balance sheets as total assets. When evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM reviews several key metrics included in net income (loss) and total assets, which include the following:

 

    For the
three months
ended
September 30,
2026
    For the
period from
January 5,
2026
(inception)
through
September 30,
2026
 
Formation and operating costs   $ 118,072     $ 399,357  
Loss from operations     (118,072 )     (399,357 )
Interest income on cash and cash equivalents     3,890       5,160  
Interest income on marketable securities held in trust account     1,038,267       1,070,637  
Total other income     1,042,157       1,075,797  
Net income   $ 924,086     $ 676,441  

 

11

 

ALPEX ACQUISITION CORPORATION

 

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

September 30, 2026

 

    As of
September 30,
2026
 
Cash and marketable securities held in trust account   $ 116,070,637  

 

The CODM reviews income earned on the Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the Trust Agreement.

 

Formation and operating costs are reviewed and monitored by the CODM to manage and forecast cash to ensure that enough capital is available to complete a Business Combination or similar transaction within the Business Combination period. The CODM also reviews formation and operating costs to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. Formation and operating costs, as reported on the accompanying unaudited statements of operations, are the significant segment expenses provided to the CODM on a regular basis.

 

All other segment items included in net loss are reported on the accompanying unaudited statements of operations and described within their respective disclosures.

 

NOTE 10 SUBSEQUENT EVENTS

 

The Company evaluated subsequent events through November 20, 2026, the date these financial statements were issued.

 

In November 2026, the Company entered into a non-binding letter of intent with a prospective target regarding a potential business combination. The letter of intent includes certain binding provisions relating to confidentiality, exclusivity and expenses. The proposed transaction remains subject to due diligence, negotiation and execution of definitive agreements, and applicable approvals. There can be no assurance that a definitive agreement will be executed or that the proposed transaction will be completed. The financial effect of the proposed business combination cannot be reasonably estimated at this time.

 

12

 

ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

This discussion should be read together with the unaudited condensed financial statements and accompanying notes in Item 1. Forward-looking statements involve uncertainty; transaction timing, financing and future costs may differ from current expectations.

 

Overview

 

We are a Cayman Islands special purpose acquisition company formed on January 5, 2026. We completed our IPO on June 26, 2026 and are pursuing an initial business combination. We had not completed a business combination or generated operating revenue at September 30, 2026. Our activities include evaluating opportunities, engaging advisers and satisfying our public-company obligations. Our fiscal year ends December 31.

 

Each IPO unit included a Class A share, a warrant and a right to one-fourth of a Class A share. The IPO raised $115.0 million, and the Sponsor’s concurrent private placement provided $1.8 million cash and a $75,000 noncash offset. We initially funded the Trust Account with $115.0 million. We must complete a business combination by June 26, 2027 unless the period is validly extended.

 

Results of operations

 

   Three months ended September 30,
2026
   January 5, 2026 (inception) through September 30,
2026
 
Formation and operating costs   118,072    334,956 
Share-based compensation   -    64,401 
Total operating expenses   118,072    399,357 
Operating-account interest income   3,890    5,160 
Income earned on investments held in the Trust Account   1,038,267    1,070,637 
Net income   924,086    676,441 

 

For the three months ended September 30, 2026, net income was $924,086. Investment and interest income of $1,042,157 exceeded operating expenses of $118,072. Trust income contributed $1,038,267 and operating-account interest contributed $3,890. Operating expenses included $30,000 of D&O insurance expense, $30,000 of accounting and audit fees, $9,166 of executive compensation, $22,215 of professional fees and $26,690 of other G&A costs.

 

For the period from January 5, 2026 (inception) through September 30, 2026, net income was $676,441, reflecting $1,075,797 of interest and investment income and $399,357 of operating expenses. Costs included Company formation, IPO readiness, Nasdaq listing, audit and accounting services, executive compensation, insurance, professional services and the director award. No comparable 2025 period exists because the Company was formed in 2026.

 

The positive net income primarily reflects restricted trust investment earnings. It is not operating revenue, and it does not indicate that unrestricted cash increased. The $1,038,267 quarter-end increase in the redemption value of public shares was recorded in equity and did not reduce net income. The $64,401 director award was a noncash expense and Sponsor contribution; it did not issue new shares or consume Company cash.

 

13

 

Liquidity and capital resources

 

At September 30, 2026, we had $282,656 of cash outside trust, $466,781 of prepaid expenses, including $291,781 of prepaid financial-advisory services. The Trust Account held $116,070,637, consisting of the initial deposit and reinvested earnings. Trust principal is restricted and is not available to meet ordinary operating expenditures. Current liabilities were $226,653, including $209,653 due under the Promissory Note and $17,000 of accrued expenses. A further $805,000 of deferred underwriting compensation is payable upon a business combination under the existing agreement.

 

January 5, 2026 (inception) through September 30, 2026   Cash flow  
Operating activities     (691,026 )
Investing activities     (115,000,000 )
Financing activities     115,973,682  
Net increase in cash     282,656  

 

Net cash used in operating activities was $691,026. Net income of $676,441 was adjusted for $1,070,637 of trust income retained in trust, $92,925 of costs paid directly by the Sponsor, $5,000 of deferred offering costs written off and $64,401 of noncash share compensation. Operating asset and liability changes used a net $459,156, comprising $466,781 of prepaid expenses, partially offset by $7,625 of adjusted accrued-liability changes. The $9,375 Promissory Note reclassification was excluded from cash flows.

 

Investing cash outflows were $115,000,000 for the initial Trust Account funding. Financing inflows of $115,973,682 comprised $115,000,000 of public offering receipts, $1,800,000 of private placement cash and a $1,000 Sponsor contribution, less $827,318 of offering costs paid. The $75,000 private placement offset, $25,000 founder subscription offset, deferred underwriting commission and representative-share compensation were noncash items.

 

During the third quarter, significant cash uses included a $300,000 financial advisory payment and a $75,000 initial payment under the legal engagement letter. The unconsumed portions of both payments are included in prepaid expenses. Advisory expense of $8,219 was recognized for September 21–30, 2026. We expect to incur further advisory and legal costs while pursuing a business combination. Prepaid advisory and legal fees are recognized as expenses as the related services are received.

 

Going concern and financing plans

 

Our available operating cash is limited compared with the costs of evaluating and completing a transaction and meeting public-company obligations. We may seek Sponsor or third-party financing, but no potential source should be treated as assured without a commitment. The business-combination deadline and liquidity conditions raise substantial doubt about our ability to continue as a going concern for one year after issuance. Failure to obtain funding or complete a transaction could require us to curtail activities and ultimately redeem the public shares and liquidate. See Note 1 for management’s assessment and plans.

 

Commitments and critical accounting judgments

 

Our significant arrangements include the deferred underwriting commission, the Promissory Note, advisory and legal engagements and the IPO registration-rights and indemnification arrangements. Notes 5 through 7 describe their accounting and outstanding balances.

  

Significant judgments include the classification and redemption measurement of public shares; allocation of IPO proceeds and issuance costs; equity classification of rights and warrants; valuation of the independent-director shares; service-period recognition and recoverability of prepaid advisory fees; and earnings per share. The independent-director measurement uses an estimated transaction probability and marketability adjustment. Changes in relevant assumptions could affect the measurement; the recorded equity-classified award is not subsequently remeasured solely for changes in the share price.

 

We do not currently have operating revenue. The CODM monitors the cash position, trust earnings and transaction-related expenditures within a single reportable segment. Additional segment information and the current significant expenses are included in Note 9.

 

14

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and are not required to provide the information otherwise required under this item.

 

ITEM 4. CONTROLS AND PROCEDURES  

 

Evaluation of Disclosure Controls and Procedures

 

Disclosure controls and procedures are designed to provide reasonable assurance that information required in reports filed under the Exchange Act is recorded, processed, summarized and reported within the SEC’s prescribed time periods and communicated to management, including our Chief Executive Officer and Chief Financial Officer, to permit timely disclosure decisions. Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of September 30, 2026 pursuant to Rule 13a-15(b) under the Exchange Act. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of September 30, 2026.

 

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

 

This Quarterly Report does not include an attestation report of internal controls from our independent registered public accounting firm due to our status as an emerging growth company under the JOBS Act.

 

Changes in Internal Control Over Financial Reporting

 

During the quarter ended September 30, 2026, there were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

15

 

PART II - OTHER INFORMATION

 

 

ITEM 1. LEGAL PROCEEDINGS.

 

We are not a party to any material legal proceedings and no material legal proceedings have been threatened by us or, to the best of our knowledge, against us. 

 

ITEM 1A. RISK FACTORS.

 

As a smaller reporting company, we are not required to include risk factors in this Quarterly Report. However, factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in the prospectus related to the IPO (File No. 333-294978) (the “Prospectus”). Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in the Prospectus.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS FROM REGISTERED SECURITIES.

  

There were no unregistered sales of equity securities by the Company during the quarter ended September 30, 2026. The IPO closed on June 26, 2026. The use of IPO and private placement proceeds, including the $115,000,000 initially deposited in the Trust Account, is discussed in Item 2 of Part I under Liquidity and Capital Resources.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES.

 

Not applicable.

 

ITEM 5. OTHER INFORMATION.

 

None.

 

ITEM 6. EXHIBITS

 

The exhibits below are filed, furnished or incorporated by reference with this report.

 

Exhibit No.   Description
31.1*   Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*   Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**   Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**   Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*   Inline XBRL Instance Document
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.SCH*   Inline XBRL Taxonomy Extension Schema Document
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*   Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104*   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Filed herewith
** Furnished.

 

16

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Alpex Acquisition Corporation
     
Date: November 20, 2026 By: /s/ Xiaolin Zheng
    Xiaolin Zheng
    Chief Executive Officer (Principal Executive Officer)
     
Date: November 20, 2026 By: /s/ Ying Xu
    Ying Xu
    Chief Financial Officer (Principal Financial Officer)

 

17

 

Keep reading